
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
MYC regulates the antitumor immune response through CD47 and PD-L1
Stephanie C. Casey, Ling Tong, Yulin Li, et al.
Science (2016) Vol. 352, Iss. 6282, pp. 227-231
Open Access | Times Cited: 1177
Stephanie C. Casey, Ling Tong, Yulin Li, et al.
Science (2016) Vol. 352, Iss. 6282, pp. 227-231
Open Access | Times Cited: 1177
Showing 1-25 of 1177 citing articles:
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo, et al.
Cell (2017) Vol. 168, Iss. 4, pp. 707-723
Open Access | Times Cited: 4421
Padmanee Sharma, Siwen Hu‐Lieskovan, Jennifer A. Wargo, et al.
Cell (2017) Vol. 168, Iss. 4, pp. 707-723
Open Access | Times Cited: 4421
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani, Federica Marchesi, Alberto Malesci, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 7, pp. 399-416
Open Access | Times Cited: 3276
Alberto Mantovani, Federica Marchesi, Alberto Malesci, et al.
Nature Reviews Clinical Oncology (2017) Vol. 14, Iss. 7, pp. 399-416
Open Access | Times Cited: 3276
TISIDB: an integrated repository portal for tumor–immune system interactions
Beibei Ru, Ching Ngar Wong, Yin Tong, et al.
Bioinformatics (2019) Vol. 35, Iss. 20, pp. 4200-4202
Closed Access | Times Cited: 1860
Beibei Ru, Ching Ngar Wong, Yin Tong, et al.
Bioinformatics (2019) Vol. 35, Iss. 20, pp. 4200-4202
Closed Access | Times Cited: 1860
Regulation and Function of the PD-L1 Checkpoint
Chong Sun, Riccardo Mezzadra, Ton N. Schumacher
Immunity (2018) Vol. 48, Iss. 3, pp. 434-452
Open Access | Times Cited: 1835
Chong Sun, Riccardo Mezzadra, Ton N. Schumacher
Immunity (2018) Vol. 48, Iss. 3, pp. 434-452
Open Access | Times Cited: 1835
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Massimo Locati, Graziella Curtale, Alberto Mantovani
Annual Review of Pathology Mechanisms of Disease (2019) Vol. 15, Iss. 1, pp. 123-147
Open Access | Times Cited: 1523
Massimo Locati, Graziella Curtale, Alberto Mantovani
Annual Review of Pathology Mechanisms of Disease (2019) Vol. 15, Iss. 1, pp. 123-147
Open Access | Times Cited: 1523
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Xianjie Jiang, Jie Wang, Xiangying Deng, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 1168
Xianjie Jiang, Jie Wang, Xiangying Deng, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 1168
Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
Mauro Poggio, Tianyi Hu, Chien-Chun Steven Pai, et al.
Cell (2019) Vol. 177, Iss. 2, pp. 414-427.e13
Open Access | Times Cited: 1106
Mauro Poggio, Tianyi Hu, Chien-Chun Steven Pai, et al.
Cell (2019) Vol. 177, Iss. 2, pp. 414-427.e13
Open Access | Times Cited: 1106
Neutrophil diversity and plasticity in tumour progression and therapy
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 885
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 885
Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance
Jinfang Zhang, Xia Bu, Haizhen Wang, et al.
Nature (2017) Vol. 553, Iss. 7686, pp. 91-95
Open Access | Times Cited: 831
Jinfang Zhang, Xia Bu, Haizhen Wang, et al.
Nature (2017) Vol. 553, Iss. 7686, pp. 91-95
Open Access | Times Cited: 831
Tumor Microenvironment Characterization in Gastric Cancer Identifies Prognostic and Immunotherapeutically Relevant Gene Signatures
Dongqiang Zeng, Meiyi Li, Rui Zhou, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 5, pp. 737-750
Open Access | Times Cited: 774
Dongqiang Zeng, Meiyi Li, Rui Zhou, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 5, pp. 737-750
Open Access | Times Cited: 774
Mechanisms Controlling PD-L1 Expression in Cancer
Jong‐Ho Cha, Li-Chuan Chan, Chia‐Wei Li, et al.
Molecular Cell (2019) Vol. 76, Iss. 3, pp. 359-370
Open Access | Times Cited: 756
Jong‐Ho Cha, Li-Chuan Chan, Chia‐Wei Li, et al.
Molecular Cell (2019) Vol. 76, Iss. 3, pp. 359-370
Open Access | Times Cited: 756
Phagocytosis checkpoints as new targets for cancer immunotherapy
Mingye Feng, Wen Jiang, Betty Y.S. Kim, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 568-586
Open Access | Times Cited: 753
Mingye Feng, Wen Jiang, Betty Y.S. Kim, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 10, pp. 568-586
Open Access | Times Cited: 753
Genetics and biology of prostate cancer
Guocan Wang, Di Zhao, Denise J. Spring, et al.
Genes & Development (2018) Vol. 32, Iss. 17-18, pp. 1105-1140
Open Access | Times Cited: 643
Guocan Wang, Di Zhao, Denise J. Spring, et al.
Genes & Development (2018) Vol. 32, Iss. 17-18, pp. 1105-1140
Open Access | Times Cited: 643
Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy
Jinyang Li, Katelyn T. Byrne, Fangxue Yan, et al.
Immunity (2018) Vol. 49, Iss. 1, pp. 178-193.e7
Open Access | Times Cited: 632
Jinyang Li, Katelyn T. Byrne, Fangxue Yan, et al.
Immunity (2018) Vol. 49, Iss. 1, pp. 178-193.e7
Open Access | Times Cited: 632
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Weitong Gao, Yuqin Wang, Yang Zhou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 612
Weitong Gao, Yuqin Wang, Yang Zhou, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 612
Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
Riccardo Mezzadra, Chong Sun, Lucas T. Jae, et al.
Nature (2017) Vol. 549, Iss. 7670, pp. 106-110
Open Access | Times Cited: 605
Riccardo Mezzadra, Chong Sun, Lucas T. Jae, et al.
Nature (2017) Vol. 549, Iss. 7670, pp. 106-110
Open Access | Times Cited: 605
Impact of oncogenic pathways on evasion of antitumour immune responses
Stefani Spranger, Thomas F. Gajewski
Nature reviews. Cancer (2018) Vol. 18, Iss. 3, pp. 139-147
Open Access | Times Cited: 577
Stefani Spranger, Thomas F. Gajewski
Nature reviews. Cancer (2018) Vol. 18, Iss. 3, pp. 139-147
Open Access | Times Cited: 577
The MYC oncogene — the grand orchestrator of cancer growth and immune evasion
Renumathy Dhanasekaran, Anja Deutzmann, Wadie D. Mahauad‐Fernandez, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 23-36
Open Access | Times Cited: 564
Renumathy Dhanasekaran, Anja Deutzmann, Wadie D. Mahauad‐Fernandez, et al.
Nature Reviews Clinical Oncology (2021) Vol. 19, Iss. 1, pp. 23-36
Open Access | Times Cited: 564
Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes
Deborah B. Doroshow, Miguel F. Sanmamed, Katherine Hastings, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 15, pp. 4592-4602
Open Access | Times Cited: 559
Deborah B. Doroshow, Miguel F. Sanmamed, Katherine Hastings, et al.
Clinical Cancer Research (2019) Vol. 25, Iss. 15, pp. 4592-4602
Open Access | Times Cited: 559
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Matthew A. Coelho, Sophie de Carné Trécesson, Sareena Rana, et al.
Immunity (2017) Vol. 47, Iss. 6, pp. 1083-1099.e6
Open Access | Times Cited: 532
Matthew A. Coelho, Sophie de Carné Trécesson, Sareena Rana, et al.
Immunity (2017) Vol. 47, Iss. 6, pp. 1083-1099.e6
Open Access | Times Cited: 532
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
Shogo Kumagai, Shohei Koyama, Kota Itahashi, et al.
Cancer Cell (2022) Vol. 40, Iss. 2, pp. 201-218.e9
Open Access | Times Cited: 522
Shogo Kumagai, Shohei Koyama, Kota Itahashi, et al.
Cancer Cell (2022) Vol. 40, Iss. 2, pp. 201-218.e9
Open Access | Times Cited: 522
Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
Max D. Wellenstein, Karin E. de Visser
Immunity (2018) Vol. 48, Iss. 3, pp. 399-416
Open Access | Times Cited: 514
Max D. Wellenstein, Karin E. de Visser
Immunity (2018) Vol. 48, Iss. 3, pp. 399-416
Open Access | Times Cited: 514
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
Roderik M. Kortlever, Nicole M. Sodir, Catherine H. Wilson, et al.
Cell (2017) Vol. 171, Iss. 6, pp. 1301-1315.e14
Open Access | Times Cited: 467
Roderik M. Kortlever, Nicole M. Sodir, Catherine H. Wilson, et al.
Cell (2017) Vol. 171, Iss. 6, pp. 1301-1315.e14
Open Access | Times Cited: 467
The CD47-SIRPα Immune Checkpoint
Meike E. W. Logtenberg, Ferenc A. Scheeren, Ton N. Schumacher
Immunity (2020) Vol. 52, Iss. 5, pp. 742-752
Open Access | Times Cited: 465
Meike E. W. Logtenberg, Ferenc A. Scheeren, Ton N. Schumacher
Immunity (2020) Vol. 52, Iss. 5, pp. 742-752
Open Access | Times Cited: 465
Targeting the epigenetic regulation of antitumour immunity
Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 11, pp. 776-800
Closed Access | Times Cited: 457
Simon J. Hogg, Paul A. Beavis, Mark A. Dawson, et al.
Nature Reviews Drug Discovery (2020) Vol. 19, Iss. 11, pp. 776-800
Closed Access | Times Cited: 457